Title: Predictive value of fibrinogen in identifying inflammatory bowel disease in active stage
Version: 0 Date: 23 Sep 2021
Reviewer's report:
- “despite of many efforts to discover new biomarkers.”
Add some citation (for example, “Caviglia GP et al. Fecal calprotectin: beyond intestinal organic
diseases. Panminerva Med. 2018 Mar;60(1):29-34. doi: 10.23736/S0031-0808.18.03405-5.
Epub 2018 Jan 25. PMID: 29370679.”)
- “IBD patients”
Use “patients with IBD”
- Explain better in the methods in what moment of the disease (how many year) the patients
were recruited
- Add a space between Table 2 and 3, Table 3 and 4
- In table 4 specific the sex (male?)
- Compare fibrinogen AUC (ROC curve analysis) versus erythrocyte sedimentation rate (ESR)
and versus calprotectin in UC and versus CRP in CD
Title: Predictive value of fibrinogen in identifying inflammatory bowel disease in active stage
Version: 0 Date: 23 Sep 2021
Reviewer's report:
- “despite of many efforts to discover new biomarkers.”
Add some citation (for example, “Caviglia GP et al. Fecal calprotectin: beyond intestinal organic
diseases. Panminerva Med. 2018 Mar;60(1):29-34. doi: 10.23736/S0031-0808.18.03405-5.
Epub 2018 Jan 25. PMID: 29370679.”)
- “IBD patients”
Use “patients with IBD”
- Explain better in the methods in what moment of the disease (how many year) the patients
were recruited
- Add a space between Table 2 and 3, Table 3 and 4
- In table 4 specific the sex (male?)
- Compare fibrinogen AUC (ROC curve analysis) versus erythrocyte sedimentation rate (ESR)
and versus calprotectin in UC and versus CRP in CD
Please review this paper.
user
Title: Predictive value of fibrinogen in identifying inflammatory bowel disease in active stage
Version: 0 Date: 23 Sep 2021
Reviewer's report:
- “despite of many efforts to discover new biomarkers.”
Add some citation (for example, “Caviglia GP et al. Fecal calprotectin: beyond intestinal organic
diseases. Panminerva Med. 2018 Mar;60(1):29-34. doi: 10.23736/S0031-0808.18.03405-5.
Epub 2018 Jan 25. PMID: 29370679.”)
- “IBD patients”
Use “patients with IBD”
- Explain better in the methods in what moment of the disease (how many year) the patients
were recruited
- Add a space between Table 2 and 3, Table 3 and 4
- In table 4 specific the sex (male?)
- Compare fibrinogen AUC (ROC curve analysis) versus erythrocyte sedimentation rate (ESR)
and versus calprotectin in UC and versus CRP in CD
assistant